Ovid Therapeutics Vs. GlycoMimetics Industry Stock Comparison

Sell

16

OVID
Ovid Therapeutics

Last Price:

1.17

Seasonality Move:

-0.74%

Sell

25

GLYC
GlycoMimetics

Last Price:

0.17

Seasonality Move:

21.08%

Sell

16

Ovid Therapeutics (OVID) is a Sell

Is Ovid Therapeutics a Buy, Sell or Hold?

The current Ovid Therapeutics [OVID] share price is $1.17. The Score for OVID is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
OVID is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

25

GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

The current GlycoMimetics [GLYC] share price is $0.17. The Score for GLYC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
GLYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OVID Stock Price Chart

What is Ovid Therapeutics's stock price today?

The Ovid Therapeutics share price today is $1.17
The current trend is relatively stagnant and OVID is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

The GlycoMimetics share price today is $0.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLYC is experiencing slight buying pressure.

OVID Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.01	Buy
Relative Strength Index (14 RSI):	53.54	Buy
Chaikin Money Flow:	92348	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.08 - 1.22)	Buy
Bollinger Bands (100):	(0.7 - 2.72)	Sell

GLYC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	44.31	Sell
Chaikin Money Flow:	-98091	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.16 - 0.18)	Buy
Bollinger Bands (100):	(-0.01 - 0.63)	Sell

OVID Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.13	Buy
20-day SMA:	1.15	Buy
50-day SMA:	1.06	Buy
200-day SMA:	2.51	Sell
8-day EMA:	1.13	Buy
20-day EMA:	1.12	Buy
50-day EMA:	1.22	Sell
200-day EMA:	2.16	Sell

GLYC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.16	Buy
20-day SMA:	0.17	Sell
50-day SMA:	0.21	Sell
200-day SMA:	1.49	Sell
8-day EMA:	0.17	Buy
20-day EMA:	0.17	Sell
50-day EMA:	0.24	Sell
200-day EMA:	1	Sell

Ovid Therapeutics Earnings Growth & OVID Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.23 per share.

GlycoMimetics Earnings Growth & GLYC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.12 per share.

Ovid Therapeutics Technical Analysis

	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19
	Sep
	06	09	10	11	12	13	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GlycoMimetics Technical Analysis

	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19
	Sep
	06	09	10	11	12	13	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):